Showing results (21-30 of 17,194) with videos related to

Sort By:
Pageof 1,720
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1991
A phase II trial of intraperitoneal cisplatin and etoposide as salvage treatment for minimal residual ovarian carcinomaS Kirmani, W E Lucas, S Kim, et al.
Cancer Treatment Reports|March 1, 1986
Lack of synergy between cisplatin and cytarabine against ovarian carcinoma in vitroS B Howell, S Gill
Cancer Treatment Reports|June 1, 1983
Preclinical re-evaluation of benzaldehyde as a chemotherapeutic agentR Taetle, S B Howell
Gynecologic Oncology|June 1, 1993
High-dose biweekly intraperitoneal cisplatin: an effective way to increase cisplatin dose intensityA Bonetti, S B Howell, E McClay, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1993
Dose intensification of cisplatin chemotherapy through biweekly administrationS Kim, S B Howell, E McClay, et al.
Hematology/Oncology Clinics of North America|August 1, 1992
Intraperitoneal therapy in the management of patients with ovarian cancerE F McClay, S B Howell
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Role of hypoxanthine and thymidine in determining methotrexate plus dipyridamole cytotoxicityT C Chan, S B Howell
Cancer Drug Delivery|January 1, 1986
Peritoneal access for intracavitary chemotherapyS B Howell, C E Pfeifle
Cancer Cells (Cold Spring Harbor, N.Y. : 1989)|February 1, 1990
Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistanceP A Andrews, S B Howell
Pageof 1,720